Biogen Idec Inc.

Exporter
14 Cambridge Ctr., Cambridge, MA 02142-1453, United States
(617)679-2000, (617)679-2617 fax, http://www.biogen.com

Primary SIC: Biological Products Except Diagnostic, Primary NAICS: Biological Product (except Diagnostic) Manufacturing
Description: Biogen Idec Inc. started in 1978, incorporated in California in 1985, and became a Delaware corporation in 1997. In November 2003, Biogen and IDEC Pharmaceuticals merged, creating Biogen Idec. The company is headquartered in Cambridge, Massachusetts, with international headquarters in Zug, Switzerland. Biogen Idec has additional offices in the U.S., Canada, Australia, Japan and throughout Europe. The company is a global leader in the discovery, development, manufacturing and commercialization of innovative therapies. Biogen Idec's business strategy is focused on discovering and developing first-in-class or best-in-class products to deliver to specialty markets globally. The company's marketed products address multiple sclerosis, non-Hodgkin's lymphoma, rheumatoid arthritis, Crohn's disease and psoriasis. Patients in more than 90 countries benefit from Biogen Idec's significant products that address medical needs in the areas of neurology, oncology and immunology. The company has 22 pipeline products in Phase 2 trials or beyond. N brands offered by the company include AVONEX, RITUXAN, TYSABRI and FUMADERM. More

Manufacturing: Biopharmaceutical company principally engaged in discovering and developing drugs for human health care through genetic engineering. Finance: Pharmaceutical licenses and patents.